Median Number of HAE Attacks/Month
Study Design A 32-week crossover study with patients ≥12 years of age with symptomatic type 1 or 2 HAE (N=90).1
Least Squares (LS) Mean Analysis The mean reduction in number of HAE attacks per month with HAEGARDA 60 IU/kg vs placebo was 84%: 0.5 (95% CI 0.0–1.0) vs 4.0 (95% CI 3.5–4.6), respectively; P<0.001.
The WAO Guideline for the Management of HAE states that patients should have HAE rescue medication available at all times2
*Median reduction in number of attacks with HAEGARDA vs placebo.
Least Squares (LS) Mean Analysis The mean reduction in number of rescue medication uses/month with HAEGARDA 60 IU/kg vs placebo was 89%.1
†Median reduction in rescue medication use vs placebo.